Mandate

Vinge advises EQT Infrastructure II in connection with its divestment of the Hector Rail group to Ancala Infrastructure

Vinge has advised EQT Infrastructure II in connection with entering into an agreement to divest the Hector Rail group to Ancala’s European Infrastructure Fund II.

Hector Rail was acquired by EQT Infrastructure II in November 2014 and is the largest private rail freight operator in Scandinavia with significant operations in Germany. With a fleet of over 100 locomotives and 400 employees, including approximately 250 train drivers, Hector Rail transports essential goods for a wide range of customers. Hector Rail also operates a growing domestic platform in Germany, the largest rail freight market in Europe, from which it focuses on attractive niche segments, such as energy and intermodal flows.

Vinge´s team consisted of Daniel Rosvall, Karl Klackenberg, Milad Kamali and Olivia Belding (M&A), Mikael Ståhl and Axel Jansson (Banking and Finance), Mathilda Persson (Commercial Agreements) and Kristoffer Sällfors (Regulatory).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025